CAR-T is the short name for Chimeric Antigen Receptor T-Cell Immunotherapy. To put it simply, CAR-T is to transform the patient's immune T cells in vitro to make them recognize the antigens on the surface of tumor cells, and then transfer these cells back to the patient to achieve the therapeutic effect of identifying and killing cancer cells.
In 2017, the US Food and Drug Administration (FDA)...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek